Chemomab Therapeutics Ltd. SC 13D and SC 13D/A reports

Location
Kiryat Atidim, Building 7, Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Data updated at
9/17/2024, 01:32 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report AMENDMENT NO. 4 Sep 16, 2024
SC 13D/A Report AMENDMENT NO. 3 Mar 11, 2024
SC 13D/A Report AMENDMENT NO. 2 Nov 15, 2023
SC 13D/A Report AMENDMENT NO. 1 Jan 5, 2023
SC 13D/A Report SC 13D/A Nov 17, 2022
SC 13D Report SC 13D Jan 20, 2022
SC 13D/A Report SC 13D/A Apr 15, 2021
SC 13D Report SCHEDULE 13D Mar 26, 2021
SC 13D/A Report SC 13D/A Dec 21, 2020
SC 13D/A Report SC 13D/A Dec 18, 2020
SC 13D/A Report SC 13D/A May 22, 2020
SC 13D/A Report SC 13D/A Mar 31, 2020
SC 13D/A Report SC 13D/A Jan 13, 2020
SC 13D/A Report SC 13D/A Dec 31, 2019
SC 13D/A Report SC 13D/A Jun 27, 2019
SC 13D/A Report PALISADE MEDICAL EQUITY I, LP Feb 25, 2019
SC 13D Report SCHEDULE 13D Feb 21, 2019
SC 13D/A Report SC 13D/A Jan 8, 2013
SC 13D/A Report SC 13D/A Dec 17, 2012
SC 13D Report SC 13D Aug 16, 2012